Found 5 matching trials
A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma
PHASE1The suppression of IGF-I and growth hormone may significantly alter the pat...
Location
National Cancer Institute (NCI)
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
PHASE3RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
PHASE3RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
Baptist Medical Center - Birmingham
Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers
PHASE1This study will assess the pharmacokinetic profile, safety and tolerability...
Location
Novartis Investigative Site
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
PHASE2This phase II trial studies how well octreotide works in reducing diarrhea ...
Location
USC/Norris Comprehensive Cancer Center